SCHEMBL30446366

SCHEMBL30446366

CC1c2ccccc2CCN1C(=O)Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 2/20 0.55
▸ NPC1 O15118 4/20 0.54
▸ POLB P06746 1/20 0.54
▸ KMT2A Q03164 6/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ RECQL P46063 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ NOD1 Q9Y239 1/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ LMNA P02545 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ OPRM1 P35372 1/20 0.47
▸ OPRK1 P41145 1/20 0.47
▸ OPRL1 P41146 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ALOX12 P18054 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25206140 1.00 DRD1 (0.55) DRD1NPC1POLBKMT2AALDH1A1
SCHEMBL25211419 0.85 KMT2A (0.60) DRD1NPC1POLBKMT2AALDH1A1
SCHEMBL23327029 0.84 NPC1 (0.68) DRD1NPC1POLBKMT2AMEN1
SCHEMBL17674616 0.82 DRD1 (0.67) DRD1NPC1POLBKMT2AALDH1A1
SCHEMBL17674575 0.82 DRD1 (0.67) DRD1NPC1POLBKMT2AALDH1A1
SCHEMBL17674681 0.82 DRD1 (0.67) DRD1NPC1POLBKMT2AALDH1A1
SCHEMBL17674643 0.81 DRD1 (0.52) DRD1NPC1POLBKMT2AMEN1
SCHEMBL17674604 0.81 TAS1R3 (0.63) DRD1NPC1POLBKMT2AMEN1
SCHEMBL17674644 0.79 DRD1 (0.61) DRD1NPC1POLBKMT2AMEN1
SCHEMBL17674718 0.78 DRD1 (0.60) DRD1NPC1POLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 Pathios Therapeutics Limited (GB) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174530-A1 N-(PHENYLAMINOCARBONYL) TETRAHYDRO-ISOQUINOLINES AND RELATED COMPOUNDS AS MODULATORS OF GPR65 GPR3, GPR65, GPR52 DRD1 868/4885NPC1 579/4885POLB 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback